Company intelligence / Profile preview

Jubilant Organosys

Noida, Uttar Pradesh, India

Ownership: Private
Development stage: Other

Overview

Jubilant Organosys was a leading Indian CRAMS and DDDS provider with a comprehensive presence across the pharmaceutical value chain, including APIs, sterile injectables, radiopharmaceuticals, drug discovery, and clinical research. It was renamed Jubilant Life Sciences in 2010 and later demerged into Jubilant Pharmova and Jubilant Ingrevia in 2021.

Industry: Drug Discovery Services

Partnerships

Eli Lilly and Company

Beyond the preview

Go deeper on Jubilant Organosys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jubilant Organosys.

Explore the full profile